Judge Fallon Oversees Bellwether Trial Selection For Xarelto Lawsuit Cases

BloodThinnerHelp.com reports on the fast approaching Xarelto bellwether trials that were selected from a larger pool of 40 cases as directed by the Honorable Judge Eldon Fallon of the Eastern District of Louisiana who is overseeing and administering the multidistrict litigation (MDL) logged as number 2592. Judge Fallon had set a date of January 11, 2016, for the pool of 40 cases to be selected from which the bellwether trials would be chosen to go to court in spring of 2017.

Xarelto has been the focus of over 2,800 lawsuits that all have similar allegations being lodged against the drug's manufacturers, Bayer Healthcare AG and Janssen Pharmaceuticals, a subsidiary company of the Johnson and Johnson Corporation. Plaintiffs have stated in their court documents that their use of Xarelto precipitated dangerous and uncontrollable bleeding, especially gastrointestinal, as well as strokes, blood clots and brain hemorrhages. Another commonality among the many lawsuits filed is that the makers of Xarelto did not adequately notify the public about the serious risks that could result from taking the drug.

As per information released from the court, Judge Eldon Fallon has scheduled the first two of four trials to be heard on February 6th and March 13th of 2017. The two subsequent trial dates have been set for April 24th and May 30th of 2017.

The purpose and intent of the Xarelto lawsuit bellwether trials is to gauge the reaction of the juries and how they may rule on the cases based on the evidentiary arguments presented by the plaintiff's and their attorneys. The bellwether trials will also provide an opportunity for plaintiffs and their attorneys to plan strategy as future trials are scheduled and they progress forward in the court system.

The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.